Share on Google Plus Share on Twitter 2 Share on Facebook 2 Share on LinkedIn Share on PInterest Share on Fark! Share on Reddit Share on StumbleUpon Tell A Friend 1 (5 Shares)  

Printer Friendly Page Save As Favorite View Favorites (# of views)   2 comments
General News

Did Anyone Notice Pharma's Black Friday?

By       Message Martha Rosenberg     Permalink
      (Page 1 of 2 pages)
Related Topic(s): ; ; ; , Add Tags Add to My Group(s)

Valuable 2   Well Said 1   Interesting 1  
View Ratings | Rate It

opednews.com Headlined to H3 11/29/11

Author 1353
Become a Fan
  (79 fans)

 

The pharmaceutical industry had two things to be thankful for this Thanksgiving season. Three new wrongdoing settlements that broke right before the holiday were buried among yam and traffic jam news--and a new sleeping pill that isn't new at all but just Ambien with a new name became a leading "news" story.

 

Of course everyone knows that the time for corporations and governments to dump bad news is Friday at 5:00 PM because no one hears the tree fall in the forest and by Monday something else will have happened. Did anyone notice that Merck pled guilty to criminal marketing of the painkiller Vioxx and agreed to pay $950 million before the holiday? In addition to the $4.85 billion it has already paid to victims?

 

Vioxx was billed as a "super-aspirin" for everyday pain until it was removed from the market in 2004 for doubling heart attack risks and causing between 27,000 and 50,000 heart events and deaths. Merck knew the heart risks and pushed Vioxx for non-approved uses according to published reports, but no corporate executives ever went up the river. "There was no basis for a finding of high-level management participation in the violation," Merck's pre-Thanksgiving news release self-congratulates.

 

Then there's Pfizer. The drug giant agreed to pay more than $60 million to resolve federal probes into alleged bribes to overseas doctors to use Pfizer drugs, reported the Wall Street Journal before the holiday. Penalties were probably reduced because Pfizer was willing to help the government by "ratting" on its competitors, says the Journal.

 

Meanwhile, the Chicago Tribune reported before Thanksgiving that Abbott is about to settle lawsuits that it illegally marketed the epilepsy drug Depakote to nursing home directors, geriatric doctors and other long-term care facilities and greased palms with kickbacks.   Abbott has set aside $1.5 billion for a settlement, says the Trib.

 

While the Merck, Pfizer and Abbott settlements may look sizeable, copping to a settlement allows drug companies to keep the Medicare and Medicaid reimbursement which is their lifeblood. Profits from the alleged wrongdoing usually dwarf penalties, too. "Even with these large fines, it is still good business to promote drugs illegally," says Dr. Adriane Fugh-Berman, director of PharmedOut, a project at Georgetown University Medical Center.

 

And there was more good news for Pharma during Thanksgiving. A newly approved sleeping pill, Intermezzo, received millions of dollars of publicity from news reports that it was a "new drug" for a "new type of insomnia" characterized by middle-of-the-night awakenings.

 

Actually, it's the same drug as Ambien and "middle-of-the-night" insomnia is one of many varieties of insomnia Pharma has rolled out to churn the insomnia drug market. Others are chronic, acute, transient, initial, delayed-onset, and terminal insomnia and don't forget non-restful sleep which can co-exist with all of the above.

Next Page  1  |  2

 

- Advertisement -

Valuable 2   Well Said 1   Interesting 1  
View Ratings | Rate It

Martha Rosenberg is an award-winning investigative public health reporter who covers the food, drug and gun industries. Her first book, Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health, is distributed by Random (more...)
 

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon



Go To Commenting
/* The Petition Site */
The views expressed in this article are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Writers Guidelines

Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Grassley Investigates Lilly/WebMD link Reported by Washington Post

The Drug Store in Your Tap Water

It's the Cymbalta Stupid

Are You Sure You're Not Psychotic Asks Shameless Drug Company?

Another Poorly Regulated "Derivative"--the Antidepressant Pristiq

MRSA and More. Antibiotics Linked to Obesity and Allergies, Too